Barinthus Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BRNS and other ETFs, options, and stocks.

About BRNS

Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. 

CEO
William Enright
CEOWilliam Enright
Employees
105
Employees105
Headquarters
Didcot, Oxfordshire
HeadquartersDidcot, Oxfordshire
Founded
2021
Founded2021
Employees
105
Employees105

BRNS Key Statistics

Market cap
43.62M
Market cap43.62M
Price-Earnings ratio
-0.62
Price-Earnings ratio-0.62
Dividend yield
—
Dividend yield—
Average volume
67.78K
Average volume67.78K
High today
$1.12
High today$1.12
Low today
$1.08
Low today$1.08
Open price
$1.11
Open price$1.11
Volume
17.05K
Volume17.05K
52 Week high
$2.92
52 Week high$2.92
52 Week low
$0.64
52 Week low$0.64
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.